🔗 Permalink

Assignee profile:

AskAt Inc.

City:

Aichi

Country:

Japan

Published Applications:

Last publication date:

2024-10-24

Patent Grants:

Last grant date:

2026-05-05

Top Inventors for applications by AskAt Inc.

These are the the leading inventors for applications assigned to AskAt Inc.:

Takako OKUMURA 7 Aichi, Japan
Shinichi KOIZUMI 4 Aichi, Japan
Yoshiyuki Okumura 4 Aichi, Japan
Yukari INAMI 3 Aichi, Japan

Fumitaka KAMACHI 2 Tokyo, Japan
Tracy WALKER 2 Craigavon, United Kingdom
Tze Mun Loo 2 Tokyo, Japan
Naoko Ohtani 2 Tokyo, Japan

Toyoharu Numata 1 Aichi, Japan
Michel Sebastiaan LEEMAN 1 Groningen, Netherlands
Hideaki HARA 1 Gifu, Japan
Masaki Sudo 1 Aichi, Japan

Yukinori TAKE 1 Aichi, Japan
Bas DROS 1 Groningen, Netherlands
Yasuhiro Iwata 1 Aichi, Japan
Kazuhiko NONOMURA 1 Aichi, Japan

Recent patent applications by AskAt Inc.

AskAt Inc. based in Aichi, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-10-24 ✅ Patent 12,617,776 granted on 2026-05-05

US20240352004A1

Chemistry; metallurgy

STABLE SALT AND CRYSTAL FORMS OF 2-[3-({1-[2-(DIMETHYLAMINO)ETHYL]-2-(2,2-DIMETHYLPROPYL)-1H-1,3-BENZODIAZOL-5-YL}SULFONYL)AZETIDIN-1-YL]ETHAN-1-OL

#2 | 2023-10-12 ✅ Patent 11,964,963 granted on 2024-04-23

US20230322737A1

Chemistry; metallurgy

Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol

#3 | 2022-05-12 ✅ Patent 11,555,023 granted on 2023-01-17

US20220144792A1

Chemistry; metallurgy

Process for the differential solubility-driven asymmetric transformation of substituted 2H-chromene-3-carboxylic acids

#4 | 2022-03-10 ✅ Patent 11,840,530 granted on 2023-12-12

US20220073510A1

Chemistry; metallurgy

Selective EP4 receptor antagonistic substance for treatment of cancer

#5 | 2019-09-05 ✅ Patent 10,583,129 granted on 2020-03-10

US20190269663A1

Human necessities

Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer

#6 | 2018-07-12 ✅ Patent 10,391,086 granted on 2019-08-27

US20180193324A1

Human necessities

Use of EP4 receptor antagonists in the treatment of cartilage disease

#7 | 2018-05-10 ✅ Patent 10,342,785 granted on 2019-07-09

US20180125832A1

Human necessities

Use of EP4 receptor antagonists for the treatment of NASH-associated liver cancer

#8 | 2017-12-21 ✅ Patent 10,786,490 granted on 2020-09-29

US20170360764A1

Human necessities

Use of EP4 receptor antagonists in the treatment of cartilage disease

#9 | 2016-01-14 ✅ Patent 9,561,210 granted on 2017-02-07

US20160008317A1

Human necessities

Therapeutic agent for ocular disease

#10 | 2015-12-10 ✅ Patent 9,447,066 granted on 2016-09-20

US20150353520A1

Chemistry; metallurgy

Salts and crystal forms

Also check out AskAt Inc.'s (Aichi, Japan) applicant profile with 10 patent applications submitted.

AssigneeID:

103018 ⎘